The latest price target for Replimune Group (NASDAQ:REPL) was reported by HC Wainwright & Co. on November 12, 2024. The analyst firm set a price target for $17.00 expecting REPL to rise to within 12 months (a possible 58.88% upside). 9 analyst firms have reported ratings in the last year.

The latest analyst rating for Replimune Group (NASDAQ:REPL) was provided by HC Wainwright & Co., and Replimune Group reiterated their buy rating.

There is no last upgrade for Replimune Group

There is no last downgrade for Replimune Group.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Replimune Group, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Replimune Group was filed on November 12, 2024 so you should expect the next rating to be made available sometime around November 12, 2025.

While ratings are subjective and will change, the latest Replimune Group (REPL) rating was a reiterated with a price target of $17.00 to $17.00. The current price Replimune Group (REPL) is trading at is $10.70, which is out of the analyst’s predicted range.